Androgen regulation of JM-27 is associated with the diseased prostate

Journal of Andrology

Volumn 25, Issue 4, 2004, Pages 618-624

  Shah, Uzma S ^a   Arlotti, Julie ^a   Dhir, Rajiv ^a,b   Lu, Sun ^c   Pirozzi, Gregorio ^c   Prakash, Kulkarni ^c   Getzenberg, Robert H ^a,b,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c Gene Logic   (United States)

^d UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Benign prostatic hyperplasia; Gene expression; Genes; Prostate cancer

Indexed keywords

ANDROGEN; CELL PROTEIN; MESSENGER RNA; POLYCLONAL ANTIBODY; PROTEIN JM 27; TESTOSTERONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASTRATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; GENE EXPRESSION REGULATION; HORMONAL REGULATION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROTEIN INDUCTION; RAT; TISSUE DISTRIBUTION;

EID: 3042814437     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: 10.1002/j.1939-4640.2004.tb02832.x     Document Type: Article

References (12)

1. Baldi E, Bonaccorsi L, Forti G. Androgen receptor: good guy or bad guy in prostate cancer invasion? Endocrinology. 2003;144:1653-1655.
2. Banerjee PP, Banerjee S, Lai JM, Strandberg JD, Zirkin BR, Brown TR. Age-dependent and lobe-specific spontaneous hyperplasia in the brown Norway rat prostate. Biol Reprod. 1998;59:1163-1170.
3. Florea L, Hartzell G, Zhang Z, Rubin GM, Miller W. A computer program for aligning a cDNA sequence with a genomic DNA sequence. Genome Res. 1998;8:967-974.
4. Jiang F, Wang Z. Identification of androgen-responsive genes in the rat ventral prostate by complementary deoxyribonucleic acid subtraction and microarray. Endocrinology. 2003;144:1257-1265.
5. Lu S, Tsai SY, Tsai MJ. Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes. Cancer Res. 1997;57:4511-4516.
6. Marker PC, Donjacour AA, Dahiya R, Cunha GR. Hormonal, cellular, and molecular control of prostatic development. Dev Biol. 2003;253: 165-174.
7. Mobbs BG, Johnson IE, Connolly JG. Hormonal responsiveness of prostatic carcinoma: in vitro technique for prediction. Urology. 1974;3: 105-106.
8. Nakano H, Watanabe M, Shiraishi T Anatomy and physiology of the prostate (in Japanese). Nippon Rinsho. 2002;60(suppl 11):7-11.
9. Nelson PS, Clegg N, Arnold H, Ferguson C, Bonham M, White J, Hood L, Lin, B. The program of androgen-responsive genes in neoplastic prostate epithelium. Proc Natl Acad Sci U S A. 2002;99:11890-11895.
10. Prakash K, Pirozzi G, Elashoff M, Munger W, Waga I, Dhir R, Kakehi Y, Getzenberg RH. Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays. Proc Natl Acad Sci U S A. 2002;99:7598-7603.
11. Thompson CJ, Tam NN, Joyce JM, Leav I, Ho SM. Gene expression profiling of testosterone and estradiol-17 beta-induced prostatic dysplasia in Noble rats and response to the antiestrogen ICI 182,780. Endocrinology. 2002;143:2093-2105.
12. Wubah JA, Fischer CM, Rolfzen LN, Khalili M, Kang J, Green JE, Bieberich CJ. Ventral prostate predominant 1, a novel mouse gene expressed exclusively in the prostate. Prostate. 2002;51:21-29.